Nodex Pharmaceutical Private Limited
About Nodex Pharmaceutical Private Limited
Data last updated:
Nodex Pharmaceutical Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U85300OR2013PTC017063. Its GSTIN is 21AAECN3920F1Z0 (Odisha).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hemanta Kumar Dash (Managing Director) and Dillip Kumar Sahoo.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 77 At – Subudhi Pur Po / Ps – Tamando, Bhubaneswar, Odisha, India – 752054.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.3 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹24,737 (net margin -4.7%) and EBITDA of -₹23,566 (EBITDA margin -4.4%). Revenue has grown at a compounded annual rate (CAGR) of 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nodex Pharmaceutical Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 77 At – Subudhi Pur Po / Ps – Tamando, Bhubaneswar, Odisha, India – 752054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nodex Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nodex Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nodex Pharmaceutical Private Limited, buy the company report.
Financials of Nodex Pharmaceutical Private Limited
FY 2023 filings availableNodex Pharmaceutical Private Limited reported revenue of ₹5.3 Lakh (down 21% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹23,566 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹24,737 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.4% | ||||
| Net Profit Margin | -4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nodex Pharmaceutical Private Limited, buy the company report.
Board of directors of Nodex Pharmaceutical Private Limited
Nodex Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dillip Kumar Sahoo Also directs: Nodex Electrotechno Private Limited | Director | 27 Jun 2013 | 13 Years 3 Months | Current |
| Hemanta Kumar Dash | Managing Director | 27 Jun 2013 | 13 Years 3 Months | Current |
Peer comparison
Nodex Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mrawbits Computing (OPC) Private Limited | ₹5.3 Lakh (FY 2022) | Kottarakara, Kerala, India | ||||
| Rentocamera Services Private Limited | ₹5.3 Lakh (FY 2025) | 49.0% | Nagpur, Maharashtra, India | |||
| Flying Farmers Private Limited | ₹5.3 Lakh (FY 2025) | 28.0% | New Delhi, Delhi, India | |||
| Stellr Lifestyle Private Limited | ₹5.3 Lakh (FY 2022) | -4.0% | Delhi, India | |||
| Akshram Remedies Private Limited | ₹5.3 Lakh (FY 2022) | -14.0% | Delhi, India | |||
| Nodex Pharmaceutical Private Limitedthis company | ₹5.3 Lakh (FY 2023) | -₹24,737 | -4.7% | -21.0% | Bhubaneswar, Odisha, India | |
| Inevia Automotiive Private Limited | ₹5.3 Lakh (FY 2024) | Faridabad, Haryana, India | ||||
| Novamount Pharmaceuticals Private Limited | ₹5.29 Lakh (FY 2025) | -15.0% | New Delhi, Delhi, India | |||
| 9Percent Ecommerce (OPC) Private Limited | ₹5.29 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Firstwave Service Private Limited | ₹5.29 Lakh (FY 2025) | 83.0% | Ranchi, Jharkhand, India | |||
| Anshul Vanijya Private Limited | ₹5.29 Lakh (FY 2025) | 2.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Nodex Pharmaceutical Private Limited, buy the company report.
Auditor
Nodex Pharmaceutical Private Limited is audited by MU ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MU ASSOCIATES | FY 2016 | 323235E |
Shareholding
The shareholding of Nodex Pharmaceutical Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nodex Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nodex Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nodex Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nodex Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAECN3920F1Z0 | Odisha | Active | 09 Mar 2021 |
To see the full GST registrations and return filing status of Nodex Pharmaceutical Private Limited, buy the company report.
Recent activity
Nodex Pharmaceutical Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Brajamohan Khatei ceased to be Director on 23 Apr 2019.
Frequently asked questions
Nodex Pharmaceutical is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 June 2013 (13+ years old) and is registered under CIN U85300OR2013PTC017063.
Nodex Pharmaceutical has 2 current directors:
- Hemanta Kumar Dash - Managing Director
- Dillip Kumar Sahoo - Director
The latest financial statements of Nodex Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Nodex Pharmaceutical is 21AAECN3920F1Z0, registered in Odisha.
The CIN (Corporate Identification Number) of Nodex Pharmaceutical is U85300OR2013PTC017063. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nodex Pharmaceutical was incorporated on 27 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Nodex Pharmaceutical by revenue are Mrawbits Computing (OPC) Private Limited, Rentocamera Services Private Limited, Flying Farmers Private Limited, Stellr Lifestyle Private Limited, Akshram Remedies Private Limited and 5 more, all in the same principal business activity (retail trading).
Brajamohan Khatei ceased to be Director on 23 Apr 2019. Dillip Kumar Sahoo was appointed as Director on 27 Jun 2013. Hemanta Kumar Dash was appointed as Managing Director on 27 Jun 2013.
The registered office of Nodex Pharmaceutical is at Plot No – 77 At – Subudhi Pur Po Ps – Tamando, Bhubaneswar, Odisha, India – 752054.
Nodex Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Nodex Pharmaceutical is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.